2014•Unpublished venueRequires access

CONSORT for Nonpharmacologic Treatments

Isabelle Boutron, Philippe Ravaud

Open publisher page 3 citations

Abstract

Nonpharmacologic treatments include a wide range of interventions such as surgery, technical operations, rehabilitation, behavioral therapy, psychotherapy, and medical devices. To overcome the inadequate reporting for studies of nonpharmacologic treatments, the CONsolidated Standards Of Reporting Trials (CONSORT) group developed an extension of the CONSORT Statement for nonpharmacologic treatments. This chapter discusses the extension in relation to the recently updated CONSORT Statement. The extension of the CONSORT Statement for nonpharmacologic treatments provides guidance for reporting the results of randomized controlled trials assessing nonpharmacologic treatments. The CONSORT extension should be used by authors when reporting results of trials assessing nonpharmacologic treatments and by editors and reviewers when evaluating such manuscripts. The CONSORT extension is designed to improve the transparency of reporting randomized nonpharmacologic trials.

About this research paper

What this paper is about

Nonpharmacologic treatments include a wide range of interventions such as surgery, technical operations, rehabilitation, behavioral therapy, psychotherapy, and medical devices. To overcome the inadequate reporting for studies of nonpharmacologic treatments, the CONsolidated Standards Of Reporting Trials (CONSORT) group developed an extension of the CONSORT Statement for nonpharmacologic treatments. This chapter discusses the extension in relation to the recently updated CONSORT Statement. The extension of the CONSORT Statement for nonpharmacologic treatments provides guidance for reporting the results of randomized controlled trials assessing nonpharmacologic treatments. The CONSORT extension should be used by authors when reporting results of trials assessing nonpharmacologic treatments and by editors and reviewers when evaluating such manuscripts. The CONSORT extension is designed to improve the transparency of reporting randomized nonpharmacologic trials.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Nonpharmacologic treatments include a wide range of interventions such as surgery, technical operations, rehabilitation, behavioral therapy, psychotherapy, and medical devices. To overcome the inadequate reporting for studies of nonpharmacologic treatments, the CONsolidated Standards Of Reporting Trials (CONSORT) group developed an extension of the CONSORT Statement for nonpharmacologic treatments. This chapter discusses the extension in relation to the recently updated CONSORT Statement. The extension of the CONSORT Statement for nonpharmacologic treatments provides guidance for reporting the results of randomized controlled trials assessing nonpharmacologic treatments. The CONSORT extension should be used by authors when reporting results of trials assessing nonpharmacologic treatments and by editors and reviewers when evaluating such manuscripts. The CONSORT extension is designed to improve the transparency of reporting randomized nonpharmacologic trials.

Key concepts: Consolidated Standards of Reporting Trials, Randomized controlled trial, Medicine, Physical therapy, Transparency (behavior), Computer science, Surgery, Computer security

Related papers

Back to paper searchBrowse research topicsOriginal source
CONSORT for Nonpharmacologic Treatments — Research Paper | ScholarLens